Market News & Trends
BioXcel Expands Into CNS Orphan Disease Therapeutics
BioXcel Corporation recently announced its expansion into CNS Orphan Diseases that require novel treatment solutions for neurological manifestations, including neurodegenerative disorders, motor dysfunction disorders, and…
RedHill Biopharma Announces Collaboration With Germany's Fraunhofer Institute
RedHill Biopharma Ltd. recently announced a research collaboration with Leipzig-based Fraunhofer Institute for Cell Therapy and Immunology (IZI), a research unit of the Fraunhofer Society…
ICON Selected by Genomics England to Support Largest Genome Sequencing Project
ICON plc recently announced it has been selected by Genomics England as data management partner for the 100,000 Genomes Project. A ground-breaking project announced by…
Biota Commences Dosing in Phase II Trial of Antiviral Therapy
Biota Pharmaceuticals, Inc. recently announced that the first patient has been dosed in a Phase II double-blind, randomized, placebo-controlled trial to evaluate the safety, tolerability…
West's Daikyo Crystal Zenith® Cyclic Olefin Polymer Selected by Amgen
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, recently announced that global biotechnology leader Amgen Inc. has utilized…
NGS & Cloud Computing Driving Big Growth in Global Bioinformatics Markets
Next-generation sequencing (NGS) technology has fueled the genomics revolution, making it possible to sequence an entire human genome within days for a few thousand dollars.…
XBiotech Engages in Research for Heart Attack Antibody Therapy
XBiotech Inc., developer of True Human™ therapeutic antibodies, announced today the signing of a Material Transfer Agreement (MTA) with Brigham and Women’s Hospital and Massachusetts…
Merck’s Zepatier Will Threaten the Dominance of Gilead’s Harvoni in Hepatitis C Market
The introduction of Merck and Co.’s recently-approved drug Zepatier (elbasvir/grazoprevir) to the hepatitis C treatment space will shake up a market long-dominated by Gilead. The…
Infusion Pumps That Sense The Drug Flow - And Even Your Heartbeat - In It
By: Jonas Horn, Application Expert, Medical Liquid Flow Sensors Sensor technology takes infusion pumps to the next level by making failure detection reliable, even…
Dipexium Reaches 75% Enrollment Milestone in Pivotal Phase III Trials
Dipexium Pharmaceuticals, Inc. recently announced its OneStep-1 and OneStep-2 pivotal Phase III clinical trials have reached the 75% enrollment milestone, in the aggregate, with each…
Albumedix & Eleven Biotherapeutics Announce Albumin Variant Technology Agreement
Eleven Biotherapeutics, Inc. and Albumedix recently announced they have entered into an agreement that will see Albumedix acquire Eleven’s proprietary Supermin albumin variant assets. Albumedix…
Lonza to Build Capabilities for Drug Product Development Services, Enabling One-Stop-Shop Solutions
Lonza recently announced that its Pharma & Biotech segment is expanding its footprint to offer customers a complete portfolio of development and manufacturing services for…
Sigmoid Pharma Announces Acquisition of Freund Pharmatec Ltd.
Sigmoid Pharma Ltd recently announced it has entered into an agreement to acquire Freund Pharmatec Ltd. Through this acquisition, Sigmoid will acquire 100% ownership of…
Portola Pharmaceuticals Enters Licensing Agreements Worth Up to $120 Million
Portola Pharmaceuticals recently announced it has licensed lead development and commercial rights to its investigational agent andexanet alfa in Japan to Bristol-Myers Squibb Company and…
Enable Injections & Flex Partner for Production of Wearable High-Volume Injectors
Enable Injections Inc. recently announced it has entered into a product development and manufacturing partnership with Flex. As part of the deal, Enable Injections and…
Fibrocell Science Highlights Recent Pipeline Accomplishments
Fibrocell Science, Inc. recently highlighted several recent accomplishments related to the continued advancement of the company’s pipeline. “Recently, Fibrocell has made significant progress across our…
Trillium Therapeutics Acquires Fluorinov Pharma
FACIT has announced that Trillium Therapeutics Inc. has acquired all of the outstanding shares of privately held Fluorinov Pharma Inc., a FACIT portfolio company. The…
Sernova Announces Agreement With CCRM to Produce Specialized Cells for Diabetes Treatment
Sernova Corp recently announced it has entered into a service agreement with the Centre for Commercialization of Regenerative Medicine (CCRM) to establish, optimize, and validate…
Noxilizer Announces New Senior Vice President & CFO
Noxilizer, Inc., the company advancing a room temperature, NO2-based sterilization and decontamination process for biopharmaceutical and medical device manufacturers recently announced David A. Theil as…
AbCellera & Merck Sign Novel Therapeutic Antibody Discovery Collaboration
AbCellera recently announced a new collaboration with Merck, known as MSD outside the United States and Canada, through a subsidiary, to generate antibodies against an…